Takeda Pharmaceutical Company Limited Financial Assets At Amortised Cost
Takeda Pharmaceutical Company Limited (TAK) had Financial Assets At Amortised Cost of JPY 816.68 billion as of 2018-03-31, per its 20-F filed 2019-06-27.
Discontinued › Notes
ifrs-full:FinancialAssetsAtAmortisedCost · last filed 2019-06-27
- 2018-03-31: Financial Assets At Amortised Cost 816.68B JPY.
| Period end | Financial Assets At Amortised Cost |
|---|---|
| 2018-03-31 | 816.68B JPY 20-F · filed 2019-06-27 |